Please assess the completion status of the following clinical trial:

Trial Title: Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~To be eligible for inclusion in this trial, the patient must have moderate to severe chronic graft-versus-host disease \[defined by the National Institutes of Health (NIH) 2015 Consensus Criteria\] that started within 3 years after hematopoietic stem cell transplantation (HSCT).~Exclusion Criteria:~* Is intolerant to corticosteroids or hypersensitive to methoxsalen~* Received certain treatments during time periods disallowed by protocol~* Has infections and/or requires treatment that (per protocol or in the opinion of the investigator) might compromise:~  1. safety and well-being of participant or offspring~ 2. safety of study staff~ 3. analysis of results

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- ECP Methoxsalen + Standard of Care (Type: EXPERIMENTAL): Participants receive methoxsalen administered via ECP in addition to standard of care
- Standard of Care (Type: ACTIVE_COMPARATOR): Participants receive standard of care only

Based on this trial design, predict the completion outcome and termination type (if applicable).